In particular, the miR‐15/16 microRNA family that targets numerous cancer‐relevant factors including the anti‐apoptotic protein Bcl‐2 has been shown to function as a tumor suppressor in various tumors (Bandi et al., 2009; Bhattacharya et al., 2009; Bonci et al., 2008), and we have shown that this is also the case in MPM (Reid et al., 2013). The gene discussed is BCL2; the disease is neoplasm.